Trial Profile
Randomized phase II study of TJ-17 and TJ-114 in patients with lower limb lymphedema after lymphadenectomy for gynecologic malignancy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2022
Price :
$35
*
At a glance
- Drugs TJ 114 (Primary) ; TJ 17 (Primary)
- Indications Lymphoedema
- Focus Therapeutic Use
- 16 Aug 2022 Status changed from not yet recruiting to discontinued.
- 09 Oct 2018 New trial record